Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methanol | HCID 887 | — |
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Triphenylphosphine | HCID 11776 | — |
| Reactant | HCID 15867790 | HCID 15867790 | — |
| Catalyst | palladium(II) acetate | HCID 167845 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | HCID 178418416 | HCID 178418416 | — |
| Product | HCID 15867812 | HCID 15867812 | 38% |
Reaction Steps
Methyl (11R,12S,13E,15S,17R)-9-trifluoromethanesulfonyloxy-11,15-bis(tert-butyldimethylsiloxy)-17,20-dimethyl-7-thiaprosta-8,13-dienoate (388 mg, 0.5 mmol), palladium acetate (11.2 mg, 0.05 mmol), and triphenylphospine (26.2 g, 0.1 mmol) were dissolved in dimethylformamide (2 mL). To this were added methanol (810 μl, 20 mmol) and triethylamine (139 μl, 1 mmol). This was agitated in carbon monoxide atmosphere (1 atmosphere) at room temperature for 18 hours. 10 ml of water was added, the solution separated, and the aqueous phase was extracted with ether and the extract combined with the organic layer. The organic solution was washed with brine, then was dried over anhydrous sodium sulfate. The solution was concentrated under reduced pressure, then was purified by silica gel column chromatography (4% ethyl acetate/hexane) to obtain methyl (11R,12S,13E,15S,17R)-9-methoxycarbonyl-11,15-bis(tert-butyldimethylsiloxy)-17,20-dimethyl-7-thiaprosta-8,13-dienoate (134 mg, 38%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05990346 |
|---|
| Source dataset | uspto-grants-1999_11 |
|---|
| ORD ID | ord-a72e1cf8cafc48f38d84f84bf2c6c031 |
|---|
| Source note | uspto-grants-1999_11 |
|---|